Genetically Modified T Cells to Target Glioblastoma

Despite advances in surgical procedures, radiation, and chemotherapy the outcome for patients with glioblastoma (GBM) remains poor. While GBM cells express antigens that are potentially recognized by T cells, GBMs prevent the induction of GBM-specific immune responses by creating an immunosuppressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Krebs, Simone, Rodríguez-Cruz, Tania G., DeRenzo, Christopher, Gottschalk, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876295/
https://www.ncbi.nlm.nih.gov/pubmed/24427741
http://dx.doi.org/10.3389/fonc.2013.00322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876295/
https://www.ncbi.nlm.nih.gov/pubmed/24427741
http://dx.doi.org/10.3389/fonc.2013.00322

Ejemplares similares